Roche Obesity Pill Achieves Positive Results in Early-Stage Trial

By Adria Calatayud

Roche Holding said an oral drug candidate for the treatment of people with obesity achieved positive results in an early-stage clinical trial.

The Swiss pharmaceutical company said Wednesday that the drug, being developed to treat both type 2 diabetes and obesity, showed clinically meaningful weight loss of 7.3% after four weeks of treatment.

This is Roche's second experimental obesity drug to achieve positive results in an early-stage trial, the company said.

Write to Adria Calatayud at [e-mail]

(END) Dow Jones Newswires

07-17-24 0129ET